New PAD Guidelines; AHA on Postpartum Care; Exercise Didn't Stop CAC Progression
MSN,
Low-dose rivaroxaban (Xarelto), SGLT2 inhibitors, and GLP-1 receptor agonists have entered for the first time.
新しい PAD ガイドライン。 産後ケアに関する AHA。 運動してもCACの進行は止まらなかった
Nipponese.news,
低用量リバーロキサバン（イグザレルト）、SGLT2阻害剤、GLP-1受容体作動薬が参入 末梢動脈疾患 (PAD) に関する多社会ガイドライン 初めて。 (循環) の推奨事項
New PAD Guidelines; AHA on Postpartum Care; Exercise Didn't Stop CAC Progression
MedPage Today,
Cardiology > Prevention Recent developments of interest in cardiovascular medicine by Nicole Lou, Senior Staff Writer, MedPage…
Novel cardiac mitotrope shows promise in nonobstructive HCM
Thelimbic,
A novel cardiac mitotrope that targets myocardial energetics has shown promise in relieving symptoms and improving exercise…